this is Pebble

portable | molecular | real-time | unique

Global Molecular Diagnostic Testing Platform.
The innovative molecular diagnostic device for rapid testing at the Point-of-Care.

get it now

Pebble

Technology description

Pebble is a compact device for performing real-time colorimetric LAMP (qcLAMP). Pebble was created using three-dimensional (3D) additive manufacturing technology and operates via an Android application. The device can be used to extract rapidly quantitative information at a wide dynamic range of RNA or DNA template. Detection can occur from purified nucleic acids or directly from crude samples (swabs, saliva and biopsy tissue).

validated for :

Infectious Diseases

Pharmacogenomics (PGx)

Food, Plant & Vet Pathogens

key features

Sample-to-answer in 15 to 30 min

Quantitative

User-friendly

Lightweight

Low power consumption

Smartphone controlled

Connected

Affordable to all

biopix-t

The company behind Pebble

Our vision

Our vision is to become an innovation leader in the field of molecular diagnostics and grow into an international company with significant global presence.

Our mission

Our mission is to offer portable diagnostic devices to every potential end-user, regardless of financial status, geographical location and training. Doctors, healthcare providers and patients in both the developed and developing countries will benefit equally from our technology, which intends to alleviate personal suffering and control disease outbreaks.

Discover more

news

10.01.23

Season’s greetings with a new funding round for all!

From all of us at BIOPIX-T, we very much hope you have a Happy, Healthy and Successful New Year 2023!!!
We are about to launch a public bridge financing round in the coming weeks, followed by a full Series A round within the next two years. This bridge round will be funded by a combination of institutional investors who have already committed the majority of the necessary funds and a public crowdfunding campaign. All information about the terms and our future plans can be found by following this link: https://investors.seedblink.com/landing/2817c463e2c5f9c6 .

BIOPIX-T to participate in a H2020-RIA project granted for the early detection of Sepsis at the point-of-care!

We are pleased to announce that BIOPIX-T is participating as a design and commercialization partner, in a grant that was awarded to a consortium of 12 esteemed research institutions and companies, with the aim to develop a point-of-care device for the early detection of Sepsis.

BIOPIX-T voted by judges as top presenter in Tech Tour South East Europe 2021-2022

We are super-excited to announce that we have been selected as a winner of the 2021-2022 Tech Tour South East Europe Program after 2 rounds of intensive and competitive pitching sessions in Athens in May and online in June!

PEBBLE achieves IVDR declaration

Another important milestone achieved! Our declaration of conformity as per IVDR, for the PEBBLE qcLAMP Platform, was today approved by the Greek Organization for Medicines! We are one of the first companies in Greece to achieve the IVDR compliance for one of its products! Congratulations to all the BIOPIXers whose hard work and dedication led to this achievement!!!

more news